Analyst Research

Report Title Price
Thomson Reuters Stock Report - TELEFLEX INCORPORATED (TFX-N)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Trading Report for (TFX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
$58.00
Buy
The Investment Rate - a measure of investment demand.
Provider: Stock Traders Daily
$495.00
Buy
Teleflex Incorporated (TFX) - Medical Equipment - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Teleflex Inc Completes Sale of OEM Orthopedics Business


Thursday, 16 Aug 2012 05:00pm EDT 

Teleflex Inc announced that it has completed the previously announced sale of its OEM Orthopedics business to Tecomet. The OEM Orthopedics business is reflected as a discontinued operation in Teleflex's consolidated financial statements. Ballard Spahr LLP acted as legal counsel to Teleflex in the transaction. 

Latest Developments for Teleflex Inc

Latest Key Developments in Medical

Company Quote

Teleflex Inc
(TFX.N)
77.98
-1.27 -1.60%
4:05pm EDT